Liver Cancer: TACE, TARE, and Ablation — Non-Surgical Tre...

Cancer Treatment · 3 · January 3, 2026

Only 15-20% of hepatocellular carcinoma (HCC) patients are candidates for surgical resection or transplant at diagnosis. The remaining 80-85% rely on interventional radiology techniques — minimally invasive, catheter-based treatments that target tumors through the blood supply.

TACE: The Workhorse Treatment

Transarterial chemoembolization combines local chemotherapy with blood supply occlusion. A catheter is threaded through the femoral artery to the tumor's feeding vessels, chemotherapy is injected directly into the tumor, and the vessel is then blocked with small particles (embolization). This delivers 20-200x higher drug concentration to the tumor than IV chemo while cutting off its blood supply. TACE extends median survival from 16 to 20-26 months for intermediate-stage HCC (BCLC stage B).

TARE (Y-90 Radioembolization): Radiation from Inside

TARE delivers millions of tiny radioactive microspheres (yttrium-90) through the hepatic artery directly into the tumor's blood supply. The microspheres lodge in the tumor vasculature and deliver localized radiation over 2-4 weeks. Advantages over TACE: can be used in patients with portal vein thrombosis (a contraindication for TACE), better tolerated (less post-embolization syndrome), and can treat larger tumors. Disadvantage: higher cost ($15,000-$25,000 in the US) and requires nuclear medicine infrastructure.

Ablation: Destroying Tumors with Heat or Ice

Radiofrequency ablation (RFA) and microwave ablation (MWA) insert a needle-like probe directly into the tumor and destroy it with heat. For tumors under 3cm, ablation achieves 5-year survival rates comparable to surgical resection (60-70%). Cryoablation uses freezing instead of heat — preferred for tumors near sensitive structures. All ablation procedures are outpatient with 1-2 day recovery. Cost in India: $2,000-$5,000. In the US: $15,000-$30,000.

Cost Comparison

| Country | Cost Range (TACE (per session))

| United States | $10,000–$20,000

| India | $2,000–$5,000

| Turkey | $4,000–$8,000

| Mexico | $6,000–$12,000

Key Takeaways

- 80-85% of liver cancer patients need interventional treatments rather than surgery

- TACE delivers 20-200x higher drug concentration to tumors than IV chemotherapy

- Ablation achieves 60-70% 5-year survival for small tumors — comparable to surgery

- India offers ablation at $2,000-$5,000 vs $15,000-$30,000 in the US

Compare real-time pricing using our global cost calculator.